|
17
|
- Title: Development of AAV based ocular cell/tissue targeting technology and treatment candidates for the development of gene therapy for X-chromosome-linked retinitis pigmentosa
- Period: 2023-06-01 ~ 2026-05-31
|
 |
|
16
|
- Title: MUSCAT: Establishment and optimization of muscle cell atlas for therapeutic applications on skeletal and cardiac diseases
- Period: 2023-04-01 ~ 2027-12-31
|
 |
|
15
|
- Title: Development of Intra-muscular Injection using EN001 for the treatment of Charcot-Marie-Tooth Disease
- Period: 2023-04-01 ~ 2026-12-31
|
 |
|
14
|
- Title: Development of Advanced Early Passage Wharton's Jelly-Derived Mesenchymal Stem Cells for the Treatment of Muscle Atrophy
- Period: 2022-04-01 ~ 2025-12-31
|
 |
|
13
|
- Title: Development of quality control standard and safety evaluation technology for immuno-oncology cell-based gene therapy
- Period: 2022-02-01 ~ 2024-11-30
|
 |
|
12
|
- Title: Development of early-passage wharton’s jelly derived mesenchymal stem cell therapy for Charcot-Marie-Tooth disease
- Period: 2021-05-01 ~ 2023-03-31
|
 |
|
11
|
- Title: Development of technology regulating senescence of human mesenchymal stem cells using gut microbiota derived metabolites
- Period: 2021-06-01 ~ 2024-05-31
|
 |
|
10
|
- Title: of microbiome regulation mechanism by mesenchymal Stem Cells for treatment of Duchenne muscular dystrophy
- Period: 2021-06-01 ~ 2023-05-31
|
 |
|
9
|
- Title: Development of Advanced Early Passage Wharton's Jelly-Derived Mesenchymal Stem Cells for the Treatment of Duchenne Muscular Dystrophy through GMP Based Large Scale Production
- Period: 2020-09-01 ~ 2022-08-31
|
 |
|
8
|
- Title: Grant Voucher for AI Technology Development 2020
- Period: 2020-09-01 ~ 2020-12-31
|
 |
